Darolutamide showed similar benefits for Black patients as observed in the overall population
Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had clinical outcomes similar to those observed in the overall clinical trial population, according ...
Oct 6, 2021
0
18